How InterStim Implant Works for Sacral Nerve Stimulation
The InterStim implant works by delivering continuous pulsed electrical stimulation to the sacral nerves through a battery-operated stimulator, modulating nerve activity to improve bowel control and reduce fecal incontinence episodes. 1, 2
Mechanism of Action
InterStim therapy operates through the following mechanisms:
- Sacral nerve modulation: The device targets the S3 sacral nerve root, which controls bowel, bladder, and pelvic floor function 1
- Electrical stimulation: Continuous low-level electrical pulses are delivered to normalize neural communication between the bowel and brain 2
- Two-phase implementation:
- Initial test phase with temporary external stimulator (2-3 weeks)
- Permanent implantation if ≥50% reduction in symptoms is achieved 1
Clinical Implementation Process
Patient selection: Candidates include those with moderate to severe fecal incontinence who have failed conservative management and biofeedback therapy 2
Test stimulation phase:
- Temporary lead placement near sacral nerves
- External stimulator provides test stimulation for 2-3 weeks
- Success defined as ≥50% reduction in fecal incontinence episodes 1
Permanent implantation:
Efficacy and Outcomes
InterStim therapy demonstrates significant clinical benefits:
- Long-term efficacy: 89% of patients show therapeutic success at 5-year follow-up 1
- Complete continence: Achieved in 36% of patients with long-term use 1
- Symptom reduction: Average reduction from 9.4 to 1.7 incontinent episodes per week 3
- Quality of life: Significant improvements in all domains of fecal incontinence quality of life measures 3
Physiological Effects
The exact mechanism remains somewhat unclear, but research suggests InterStim works by:
- Inducing colonic retrograde propagated sequences: May delay colonic transit 1
- Normalizing pelvic floor function: Improves coordination between sphincter muscles 2
- Modulating sensory pathways: May improve rectal sensation and awareness 1
Important Considerations
- Battery replacement: Required approximately every 7 years 1
- Common adverse events: Pain at implant site (28%), paresthesia (15%), changes in stimulation sensation (12%), and infection (10%) 3
- Contraindications: Not typically recommended for patients with large external sphincter defects (>120°) 1
Comparative Effectiveness
- Superior to medical treatment: Randomized controlled trials show better outcomes compared to medication alone 1
- Similar to PTNS: Not significantly better than percutaneous tibial nerve stimulation in direct comparisons 1
- Cost considerations: More expensive than conservative approaches at approximately $35,818 (2013 dollars) 1
InterStim therapy represents an effective minimally invasive surgical option for carefully selected patients with fecal incontinence who have failed conservative approaches.